Angelo Gordon & Co’s Surmodics SRDX Stock Holding History

Angelo Gordon & Co’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,042	Closed	-$210K	–	69
2025 Q3	$210K	Sell	7,042 -32,958	-82%	-$1.1M	0.03%	47
2025 Q2	$1.19M	Hold	40,000	–	–	0.16%	41
2025 Q1	$1.22M	Buy	40,000 +15,000	+60%	+$505K	0.21%	37
2024 Q4	$990K	Buy	25,000 +3,840	+18%	+$149K	0.2%	37
2024 Q3	$821K	Sell	21,160 -3,840	-15%	-$155K	0.23%	36
2024 Q2	$1.05M	Buy	+25,000	New	+$853K	0.4%	30

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Angelo Gordon & Co's SRDX Position: Q4 2025 in Review

Angelo Gordon & Co sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 7,042 shares — an estimated $210K sold.

Angelo Gordon & Co first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $1.22M in Q1 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Angelo Gordon & Co reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Angelo Gordon & Co sold 7,042 Surmodics shares in Q4 2025, an estimated $210K.
Angelo Gordon & Co first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
Angelo Gordon & Co's Surmodics position peaked at $1.22M in Q1 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Angelo Gordon & Co's 13F filing for Q4 2025, filed 17 Feb 2026.